EP4129336
ANTI-CD47 AGENT-BASED TREATMENT OF CD20-POSITIVE CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.2.2019EP published:
7.5.2025EP application number:
22183160.5
EPO information:
European Patent Register
Max expiry date:
10.2.2039
Title in English:
ANTI-CD47 AGENT-BASED TREATMENT OF CD20-POSITIVE CANCERLanguage of the patent:
English
Timeline
Today
11.2.2019EP application
7.5.2025EP Publication
Owner
Name:
Forty Seven, LLCAddress:
333 Lakeside Drive, Foster City, CA 94404, US
Inventor
Name:
CHAO, Mark PingAddress:
Foster City 94404, US
Name:
TAKIMOTO, Chris Hidemi MizufuneAddress:
Foster City 94404, US
Name:
VOLKMER, Jens-PeterAddress:
Foster City 94404, US
Priority
Number:
201862629340 PDate:
12.2.2018Country:
US
Number:
201862678468 PDate:
31.5.2018Country:
US
Number:
201862743060 PDate:
9.10.2018Country:
US
Number:
201862743875 PDate:
10.10.2018Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28, A61P 35/00